Morgan Stanley Boosts Axon Enterprise (NASDAQ:AXON) Price Target to $310.00

Axon Enterprise (NASDAQ:AXON) had its price objective boosted by Morgan Stanley from $285.00 to $310.00 in a report published on Friday, Benzinga reports. The brokerage currently has an equal weight rating on the biotechnology company’s stock.

Other research analysts also recently issued research reports about the company. Needham & Company LLC reiterated a buy rating and set a $400.00 target price on shares of Axon Enterprise in a report on Wednesday, April 24th. Barclays upped their price target on Axon Enterprise from $296.00 to $308.00 and gave the stock an overweight rating in a research note on Thursday, February 29th. The Goldman Sachs Group upped their price target on Axon Enterprise from $297.00 to $339.00 and gave the stock a buy rating in a research note on Wednesday, February 28th. StockNews.com downgraded Axon Enterprise from a buy rating to a hold rating in a research note on Thursday, March 14th. Finally, TheStreet downgraded Axon Enterprise from a b rating to a c+ rating in a research note on Tuesday, February 27th. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and an average price target of $314.91.

Axon Enterprise Trading Up 0.6 %

AXON opened at $308.23 on Friday. Axon Enterprise has a one year low of $175.37 and a one year high of $329.87. The business has a 50 day simple moving average of $304.22 and a two-hundred day simple moving average of $262.21. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The firm has a market capitalization of $23.26 billion, a price-to-earnings ratio of 134.01 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The firm had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Analysts predict that Axon Enterprise will post 2.44 EPS for the current year.

Hedge Funds Weigh In On Axon Enterprise

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Brookstone Capital Management lifted its position in Axon Enterprise by 5.1% in the 1st quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after acquiring an additional 41 shares in the last quarter. HB Wealth Management LLC lifted its position in Axon Enterprise by 3.9% in the 4th quarter. HB Wealth Management LLC now owns 1,139 shares of the biotechnology company’s stock valued at $294,000 after acquiring an additional 43 shares in the last quarter. Envestnet Portfolio Solutions Inc. lifted its holdings in shares of Axon Enterprise by 1.1% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock valued at $1,033,000 after buying an additional 43 shares during the period. UMB Bank n.a. lifted its holdings in shares of Axon Enterprise by 11.0% during the 4th quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock valued at $115,000 after buying an additional 44 shares during the period. Finally, Rise Advisors LLC lifted its holdings in shares of Axon Enterprise by 49.0% during the 1st quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company’s stock valued at $45,000 after buying an additional 47 shares during the period. 79.08% of the stock is owned by institutional investors.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.